Drug Screening Market to 2027 - Abbott, Omega Laboratories, Roche Monitoring Services, Siemens Healthcare GmbH, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Premier Biotech, OraSure Technologies, Psychemedics Corporation
Drug screening is a technical process, performed for analyzing specimens such as hair, urine, oral fluids, breath and other samples. Drug screening aids in detection of drug or a chemical compound in the body. This process is applied in hospitals, drug testing centers, pain management centers as well as law enforcement agencies. Drug screening tests are also performed by companies and organizations on employees and athletes to check for drug abuse.
Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPHE100000970/?opr-ss
The consumption of alcohol and drugs has been increased during the previous years, which has been a matter of concern for various employers. Various government bodies have been providing funds for drug screening tests. These factors have fuelled the market of drug screening in the past years and the trend is expected to continue in the coming years as well. Development and adoption of new methods as well as devices for drug screening is expected to provide significant growth opportunities for the market in the future years.
The List of Companies
2. Omega Laboratories, Inc.
3. Roche Monitoring Services.
4. Siemens Healthcare GmbH
5. Thermo Fisher Scientific Inc.
6. Quest Diagnostics Incorporated
7. Premier Biotech, Inc.
8. OraSure Technologies, Inc.
9. Psychemedics Corporation
10. Laboratory Corporation of America Holdings
The global drug screening market is segmented on the basis of product type, sample and end user. Based on product type, the market is segmented as analytical instruments, rapid testing devices and consumables. On the basis of sample, the global drug screening market is segmented into breath, hair, oral fluid, urine and others. Based on end user, the market is segmented as drug testing laboratories, drug treatment centers, criminal justice systems & law enforcement agencies, pain management centers, hospitals, individuals and others.
The "Global Drug Screening Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of drug screening market with detailed market segmentation by product type, sample, end users and geography. The global drug screening market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Drug screening market players and offers key trends and opportunities in the market.
Inquire for Discount: https://www.theinsightpartners.com/discount/TIPHE100000970/?opr-ss
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global drug screening market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The drug screening market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Screening Market to 2027 - Abbott, Omega Laboratories, Roche Monitoring Services, Siemens Healthcare GmbH, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Premier Biotech, OraSure Technologies, Psychemedics Corporation here
News-ID: 1800695 • Views: 388
More Releases from The Insight Partners
Industrial Agitator Market SWOT Analysis and Segments from 2019-2027 | Xylem, SP …
According to the new research report published by The Insight Partners, titled “Industrial Agitator Market - Global Analysis and Forecast to 2027”, the global industrial agitator market is expected to reach US$ 4.65 Bn in 2027, registering a CAGR of 7.8% during the forecast period 2019-2027. Manufacturers from several industries are now a days highly focused on achieving new growth mark. Chemical industry is major revenue contributor to this market with
Security Screening Market Size, Share, Growth Analysis and Forecasts 2029-2027 | …
The global air travel industry is growing at a rapid pace. The factors such as high living standards coupled with rising middle class population particularly, in emerging markets has resulted in the increased growth. The global economic conditions as well as lower airfares are the major reason contributing to the growth. Also, progress in consumer spending related to tourism and travel in key economies has strengthened the demand for air
Aviation Test Equipment Market Outlook to 2027- Avtron Aerospace, Bauer, ECA Gro …
Aviation test equipment market in global grew from US$ 5.38 Bn in 2018 to US$ 7.69 Bn by the year 2027. This represents a CAGR of 4.1% from the year 2019 to 2027. The global aviation landscape continues to grow year on year, which is majorly influenced by the rise in passenger traffic across the globe. Owing to the fact that, every region worldwide is experiencing growth in a number of
Global Parking Management Market: A Latest Research Report to Share Market Insig …
According to a new market research study titled, “Parking Management Market To 2027 - Global Analysis and Forecasts by Parking Site, Solutions, Services, and Deployment Type”. The global market accounted for US$ 37.5 Bn in 2017 and is estimated to reach US$ 58.5 Bn by 2027 thereby registering a CAGR growth rate of 4.8% from 2019 to 2027. The report highlights the key trends prevalent in the global parking management
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning